Welcome to eviQ

A free resource of evidence-based, consensus driven cancer treatment protocols and information for use at the point of care. eviQ is developed for the Australian context and supports health professionals in the delivery of cancer treatments.

Find out more


Latest news

View all news

Expressions of interest are invited from members of the eviQ Haematology Reference Committee for the position of eviQ Haematology Reference Committee Co-Chair.

eviQ is thrilled to announce the release of the initial set of updated protocols now incorporating the ADDIKD guideline dosing recommendations. Check out our user friendly FAQ page and convenient cheat sheet, which outline the anticancer drugs that have significant changes to their kidney dosing recommendations, all based on the ADDIKD guideline.

We have created a video that highlights the upcoming changes to the eviQ protocols as we incorporate the ADDIKD guideline recommendations.

The team would like to sincerely thank Dr Nicola Poplawski for her tireless support and contribution to the eviQ cancer genetics paediatric reference committees over the past 4 years as reference committee chair.